Education
About Us
Working with TipRanks
Follow Us
Dexcom (DXCM)
:DXCM
Earnings Data
Report Date
Feb 05, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.65Last Year’s EPS
0.45Same Quarter Last Year
Strong Buy
Based on 21 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
DexCom's earnings call highlighted robust revenue growth and strategic product expansions, particularly in type 2 diabetes CGM coverage, and noted the introduction of innovative products like DexCom Smart Basal. However, challenges in gross margin management and quality issues with the G7 sensor deployment were noted. The sentiment is buoyed by positive financial performance and strategic advancements, despite some operational challenges.Company Guidance
Strong Revenue Growth
DexCom reported worldwide revenue of $1.21 billion for Q3 2025, up 22% from $994 million in Q3 2024. U.S. revenue grew by 21%, and international revenue grew by 22%, with notable performance in France and Canada.
Expansion of CGM Access
There was significant progress in CGM access, with coverage now established for nearly 6 million type 2 non-insulin lives in the U.S. This represents about half of the type 2 NIT commercial population.
Introduction of DexCom Smart Basal
DexCom Smart Basal, a titration module designed to simplify basal insulin management, is under review with the FDA and for CE Mark. It aims to improve adherence and reduce workflow for healthcare providers.
Successful Launch of Stelo
Stelo, a new product in the market for just 12 months, has surpassed $100 million in revenue and increased awareness of CGM benefits for metabolic health.
Record Earnings Per Share
DexCom reported the highest quarterly earnings per share in its history at $0.61.
DXCM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DXCM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $68.20 | $58.22 | -14.63% |
Jul 30, 2025 | $89.06 | $80.77 | -9.31% |
May 01, 2025 | $70.26 | $81.62 | +16.17% |
Feb 13, 2025 | $84.09 | $89.07 | +5.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Dexcom (DXCM) report earnings?
Dexcom (DXCM) is schdueled to report earning on Feb 05, 2026, After Close (Confirmed).
What is Dexcom (DXCM) earnings time?
Dexcom (DXCM) earnings time is at Feb 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DXCM EPS forecast?
DXCM EPS forecast for the fiscal quarter 2025 (Q4) is 0.65.
